Search Results for "XtenCHO"

Download our XtenCHO Poster

Scientific Poster Discover the XtenCHO™ transient expression system! The poster contents: The outstanding performances of our proprietary XtenCHO™ cell line A unique solution for the production of monoclonal antibodies for: Early drug development (screening & developability studies) Protein engineering (variant screening) Small to… Read More

ProteoGenix Launches New XtenCHOTM Transient CHO Expression System to Improve Biologics Development

ProteoGenix Launches New XtenCHOTM Transient CHO Expression System to Improve Biologics Development March 15, 2022 New CHO system offers ten times higher yields, optimised plasmid stability and smart protocols with less hands-on time Schiltigheim, France – ProteoGenix, a contract research organization… Read More

High Throughput Antibody Production

Read More

FAQs – Recombinant antibodies

Recombinant antibodies are one of the most successful biological reagents for research, therapy, and diagnostics. Their use has become widespread due to the enhanced batch-to-batch consistency and purity obtained by recombinant antibody production methods. On this page, we answer all most frequently asked… Read More

RECOMBINANT ANTIBODY SERVICE

Need to screen or characterize an antibody? Get 1 mg of recombinant antibody in 4 weeks to use in antibody screening, characterization, preclinical studies, and any other small-scale applications. Our proprietary mammalian expression system – XtenCHO™ – is the market’s leader… Read More

mAbs Production Services

Access to Highly-Productive Technologies for Custom mAb Production! With over 6,000 successful projects, and 3 therapeutic antibodies on the market, our access to state-of-the-art technologies and immense flexibility helps us to create unique solutions tailored to support your breakthrough discoveries in antibody development. Read More

Therapeutic Antibody Discovery Services

Discover our integrated solutions from the lab to the clinic 3 therapeutic antibodies on the market Discover our integrated solutions from the lab to the clinic 3 therapeutic antibodies on the market As a leading contract… Read More

Stable Isotope Labelling

New service Stable Isotope Labelling Get the best stable isotope-labelled compounds for your pharmacokinetics studies. Unravel the profile of your candidate drug early to design safer and more accurate clinical trials! Our solution XtenCHO™ inclusive: achieve your production & quality goals faster Labelling… Read More

ProteoGenix, a leading therapeutic antibody development service provider

In 2003, ProteoGenix was started with the idea of developing diagnostic assays and biotherapeutics to target proteins discovered by its founders. The management quickly understood the incredible value of high quality antibodies and proteins for developing biopharma products and subsequently gaining access to the difficult-to-reach clinic setting. Read More

Home

Therapeutic antibody development Antigen to bioproduction Hybridoma development Phage display services Antibody humanization Antibody affinity maturation by phage display Bispecific antibody development ADC development… Read More